Anthem considering role in Obamacare insurance in 2018

(Reuters) - Health insurer Anthem Inc on Wednesday said it expected to break even or make a small profit in the Obamacare individual market in 2017 even as it considers pulling out of that business next year.

Turkey aims to bolster local drug production, minister says

ANKARA (Reuters) - Turkey will guarantee the purchase of some medical products that international firms produce domestically, the health minister told Reuters this week, a strategy aimed at cutting reliance on imports and bringing in some $1.3 billion in new investment.

Japan's Takeda committed to single-digit U.S. drug price rises

TOKYO (Reuters) - Japan's largest drugmaker, Takeda Pharmaceuticals Co, on Wednesday said it would maintain its pricing model in the U.S. market, brushing off demands by U.S. President Donald Trump for drugmakers to offer cheaper drugs.